Reducing Posterior Capsule Opacification by Eliminating Myo/Nog Cells Through Targeted Drug Delivery
Using 3DNA Nanocarriers and the G8 Antibody
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ABSTRACT

3DNA nanocarriers are branched structures built from interconnected
monomers of natural or synthetic DNA. The 3DNA monomers are composed of
two DNA strands hybridized together with a double stranded “waist” and four
single-stranded “arms”. 3DNA is layered by successive annealing of monomer
arms. The typical 2-layer 3DNA has a diameter of approximately 70nm and
consists of approximately 4,000 bases with 36 single stranded arms. A variety
of molecules may be attached to the arms, including fluorescent reporters,
siRNAs, peptides and antibodies. Cytotoxic cargo, such as the anthracycline
antibiotic Doxorubicin, can be intercalated into the double-stranded regions of
the 3DNA.
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Quantification of PCO Following Injection of G8-3DNA-Dox During Cataract
Surgery

Distribution of Myo/Nog Cells in Human Anterior Lens Tissue
Removed During Cataract Surgery
Anterior lens tissue fixed directly after capsulorhexis was double labeled with the G8 mAb
and antibodies to Noggin (NOG), MyoD protein (MyoDp), alpha smooth muscle actin (αSMA), Vimentin (VM), the skeletal muscle specific 12101 antigen (12101), sarcomeric
myosin heavy chain (MYOSIN), and troponin T (TPNT). Tissue incubated with secondary
antibodies alone, lacked fluorescence (I-J).

Myo/Nog cells were present in low numbers throughout the lens epithelium.
Myo/Nog cells were concentrated around areas of the capsule denuded of
epithelial cells.

MyoNog cells express α-sma and skeletal muscle proteins in the anterior
lens.

Depleting Myo/Nog Cells in Anterior Lens Tissue
with G8-3DNA-DOX
Anterior lenses were incubated with the G8-3DNA-Dox or 3DNA-DOX (Control) for
24 hours after plating. Lenses were fixed and screened for G8 expression and
apoptosis using TUNEL reagents. TUNEL positive cells are red and G8 positive
cells are green. Overlap of red and green appears yellow (A-F). Some lenses were
incubated for 5 days with G8-3DNA-DOX, or with the control reagents 3DNA-DOX
and G8-3DNA (G-I). Lenses were fixed and screened for G8 (red) and α−SMA
(green).

Treatment with the G8-3DNA-DOX specifically targets and kills
Myo/Nog cells.
No G8 positive or α−SMA cells were observed in the lenses treated
with G8-3DNA-Dox.

Wrinkles appeared in the capsule in some areas surrounded by Myo/Nog
cells (arrowheads in D and H).
(Gerhart et al 2014)

Following phacoemulsion, rabbit lenses were injected with BSS, 7ug or 70ug G8-3DNA-Dox, or
70ug G8-3DNA-Dox in a hydrogel. Some animals were injected with 70ug G8-3DNA-Dox plus the
intraocular lens was soaked in 70ug G8-3DNA-Dox prior to implantation. Four weeks post
surgery the animals were culled and their globes were assessed for severity of PCO and
Soemmering’s ring formation using methods established in the laboratory at the Intermountain
Ocular Research Center (Werner L, Mamalis N, et al 2005).

Treatment with the G8-3DNA-DOX at 70ug/ml reduces central and peripheral PCO
and the intensity of Soemmering’s ring.

SUMMARY AND CONCLUSIONS
Myo/Nog cells are present in the anterior and equatorial regions of the human
lens.
In anterior lens tissue removed during cataract surgery, Myo/Nog cells are
enriched around cell free areas of the capsule. Some areas surrounded by
Myo/Nog cells contain a wrinkle in the capsule, suggesting that Myo/Nog cells
may be contractile.
3DNA nanocarriers are novel reagents for delivering cytotoxic cargo to cells.
3DNA nanocarriers can be bound with antibodies or other molecules to
specifically target a subpopulation of cells.

2-Layer DNA Nanocarrier
With G8 mAb and Doxorubicin

The purpose of this study was to test an antibody-3DNA-Doxorubicin
conjugate for specificity and toxicity in vitro and in vivo. The targeting
monoclonal antibody, called G8, recognizes a cell surface molecule on Myo/Nog
cells, so named for their expression of the skeletal muscle specific transcription
factor MyoD and the bone morphogenetic protein inhibitor Noggin (Gerhart et al
2006). Myo/Nog cells are widely distributed in the embryo and in normal and
diseased tissues of the adult (Gerhart et al 2001, 2008, 2009, 2012; Walker et al
2010). Myo/Nog cells are present in the anterior and equatorial regions of the
human lens, the cornea and ciliary body (Gerhart et al 2014). In addition to their
role as regulators of BMP signaling, Myo/Nog cells develop into myofibroblasts
in response to injury (Gerhart et al 2008, 2011, 2012, 2014; Walker et al 2010).

Treatment of anterior lens tissue in vitro and rabbit lenses in vivo with
G8-3DNA-DOX specifically targets and kills Myo/Nog cells.

Binding
Internalization
Acidification
Release of Dox
Cell Death

Injection of G8-3DNA-DOX into the rabbit lens at the time of cataract surgery
reduced PCO.
Depleting Myo/Nog cells during cataract surgery may decrease the incidence of
lens re-opacification and capsular wrinkling caused by myofibroblast-like cells.

REFERENCES
Depleting Myo/Nog Cells In Vivo

Targeted Delivery of Cytotoxic Cargo
A. Schematic representation of the G8 IgM mAb coupled to a 2-layer 3DNA nanocarrier
intercalated with Doxorubicin (G8-3DNA-DOX).
B. Proposed mechanism of targeted cytotoxicity: Doxorubicin diffuses from 3DNA following
antibody binding and internalization of the conjugate into acidic compartments of the cell.
C-E. Anterior lens tissue was incubated with Lysosensor dye that fluoresces green at an
acidic pH and G8-3DNA-Cy3 (red) for 2 hours. Co-localization of red and green appears
yellow in the merged image in E. Nuclei were labeled with Hoechst dye (blue). The cell
indicated with the arrows is enlarged in E.
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Some Myo/Nog cells had migrated onto the capsule (arrows in B).
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Methods: Anterior human lens tissue obtained by capsulorhexis was cultured in
serum free medium. Lens explants were incubated with G8-3DNA-Dox, G8-3DNA
or 3DNA-Dox. Explants were assayed for apoptosis using TUNEL. Rabbits were
injected at the time of cataract surgery with either balanced salt solution (BSS)
or G8-3DNA-Dox at doses of 7.0 or 70ug/ml. The rabbits were observed for a
period of four weeks for the development of adverse reactions, including PCO.

Conclusions: Antibody-3DNA nanocarriers are highly specific reagents for
delivering cytotoxic cargo to a subpopulation of cells. The 3DNA nanocarriers
themselves are nontoxic. Administration of G8-3DNA-Dox at the time of cataract
surgery may reduce the incidence of PCO and maintain vision.

Peripheral PCO
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Purpose: Posterior Capsule Opacification (PCO) is a vision impairing disease
that occurs in some adults and most children following cataract surgery. In
fibrotic PCO, myofibroblasts migrate onto the posterior capsule and contract to
produce wrinkles that affect visual acuity. Myofibroblasts are derived from
Myo/Nog cells that express the skeletal muscle transcription factor MyoD, the
BMP inhibitor Noggin and the G8 protein. Ex vivo depletion of Myo/Nog cells in
human lens tissue had been achieved by incubating explants with the G8
monoclonal antibody (mAb) and complement. The goal of this study was to test
the specificity and efficacy of the G8 mAb complexed to 3DNA nanocarriers
intercalated with Doxorubicin (G8-3DNA-Dox) in explants of human lens tissue
and rabbits undergoing cataract surgery.

Results: G8-3DNA-Dox specifically targeted and induced apoptosis in Myo/Nog
cells in human lens tissue. Control conjugates did not affect Myo/Nog or lens
epithelial cells. G8-3DNA-Dox also targeted Myo/Nog cells in the lens of rabbits
that underwent cataract surgery. Slit lamp, gross exam and histopathology
analyses revealed that rabbits injected with 70ug/ml of G8-3DNA-Dox had
mostly clear posterior capsules with scant areas of PCO without fibrosis.
Control rabbits injected with BSS or 7.0ug/ml G8-3DNA-Dox developed
extensive PCO and fibrosis

Central PCO

G8 mAb coupled to 3DNA is internalized into acidic compartments of the
cell.

Rabbits were injected with either balanced salt solution (BSS) or G8-3DNA-Dox at doses of
7.0 or 70ug/ml following capsulorhexis and phacoemulsion. The rabbits were observed for a
period of four weeks for the development of adverse reactions, including PCO. A few
animals were culled after 24 hours and screened for G8 expression and apoptosis using
TUNEL reagents. TUNEL positive cells are red and G8 positive cells are green. Overlap of
red and green appears yellow (A-D). After 4 weeks the remaining animals were culled and
the globes were examined for the presence of PCO (I-L). Tissue sections were screened for
G8 (red) and α−SMA (green), (E-H).

Treatment with the G8-3DNA-DOX at 70ug/ml specifically targets and kills
Myo/Nog cells.
The number of α−SMA positive cells is reduced in lenses treated with G83DNA-DOX at 70ug/ml.
Treatment with the G8-3DNA-DOX at 70ug/ml reduces PCO.
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